» Articles » PMID: 14557473

Intronic Single Nucleotide Polymorphisms in the RET Protooncogene Are Associated with a Subset of Apparently Sporadic Pheochromocytoma and May Modulate Age of Onset

Overview
Specialty Endocrinology
Date 2003 Oct 15
PMID 14557473
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 75% of pheochromocytomas are sporadic. Germline mutations in RET, VHL, SDHB, and SDHD have been shown to cause the 25% that are hereditary. Germline high penetrance gain-of-function RET mutations cause multiple endocrine neoplasia type 2, of which medullary thyroid carcinoma (MTC) and pheochromocytoma are components, whereas loss-of-function mutations cause Hirschprung disease (HSCR). A low-penetrance founder locus, in linkage disequilibrium with a RET ancestral haplotype comprising specific alleles at three intron (IVS) 1 single nucleotide polymorphisms (SNPs) (haplotype 0) and SNP A45A, predisposes to the majority of isolated HSCR. A different low-penetrance locus, in linkage disequilibrium with IVS 1 haplotype 2 and SNP S836S, was associated with a subset of sporadic MTC. We, therefore, sought to determine whether RET might also be a low-penetrance gene for apparently sporadic pheochromocytoma. We analyzed 104 pheochromocytoma cases without germline mutations in RET, VHL, SDHD, and SDHB for their status at A45, S836, three IVS 1 SNPs, and a novel upstream insertion/deletion variant. Pheochromocytoma cases were not associated with either A45A or S836S, but we found that cases were associated with haplotype 0 (P = 0.032). However, unlike HSCR, this pheochromocytoma-associated haplotype 0 was not associated with A45A. Taken together with the strengthening of association with the addition of the 5' insertion/deletion variant data (P = 0.016), our observations suggest the presence of a low-penetrance pheochromocytoma susceptibility locus in a region upstream of the putative loci for HSCR and apparently sporadic MTC.

Citing Articles

Case Report of a Prolactinoma in a Patient With a Novel Mutation and Bilateral Pheochromocytomas.

Roszko K, Blouch E, Blake M, Powers J, Tischler A, Hodin R J Endocr Soc. 2017; 1(11):1401-1407.

PMID: 29264463 PMC: 5686672. DOI: 10.1210/js.2017-00135.


Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas.

Waldmann J, Langer P, Habbe N, Fendrich V, Ramaswamy A, Rothmund M Endocrine. 2009; 35(3):347-55.

PMID: 19399650 DOI: 10.1007/s12020-009-9178-y.


RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Siraj A, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O J Endocrinol Invest. 2008; 31(10):893-9.

PMID: 19092295 DOI: 10.1007/BF03346438.


Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate.

Chiquet B, Hashmi S, Henry R, Burt A, Mulliken J, Stal S Eur J Hum Genet. 2008; 17(2):195-204.

PMID: 18716610 PMC: 2874967. DOI: 10.1038/ejhg.2008.149.


Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate.

Chiquet B, Blanton S, Burt A, Ma D, Stal S, Mulliken J Hum Mol Genet. 2008; 17(14):2212-8.

PMID: 18413325 PMC: 2852032. DOI: 10.1093/hmg/ddn121.